scholarly journals Evaluation of Carotid Artery Elastic Function Using Ultrafast Pulse Wave Velocity and Related Influential Factors in Patients with Rheumatoid Arthritis

2021 ◽  
Author(s):  
Yihan Li ◽  
Jian Zhang ◽  
Xin An ◽  
Jihui Li ◽  
Shanshan Shi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Blood Pressure ◽  
Carotid Artery ◽  
Pulse Wave Velocity ◽  
Pulse Wave ◽  
Influential Factors ◽  
Course Of Disease ◽  
Activity Group ◽  
Group A ◽  
Group B

Abstract PurposeUltrafast pulse wave velocity (UFPWV) is an innovative and practical technology that can assess the elastic function of blood vessels. This study aimed to explore the elastic function of the carotid artery using UFPWV and related influential factors in patients with rheumatoid arthritis (RA).MethodsOverall, 120 patients with RA and 60 healthy controls were evaluated. Subjects underwent UFPWV and carotid artery intima-media thickness (cIMT) examination. The patients were divided into a mild activity group (group A) and moderate-to-severe activity group (group B). Differences in clinical indicators among the groups were determined, and the correlation between each indicator and PWV value was analyzed.ResultsThe PWV values were higher in group B than in group A and were higher in group A than in the control group (P < 0.05). The BS and ES n the patient group were positively correlated with age, course of disease, systolic blood pressure (SBP), diastolic blood pressure, body mass index, total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), cIMT, rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibody, erythrocyte sedimentation rate, C-reactive protein, and platelets and were negatively correlated with 25-hydroxyvitamin D3 (25[OH]D3) and hemoglobin (P < 0.05). RF, anti-CCP antibody, age, course of disease, SBP, LDL-C, and platelets were risk factors for arteriosclerosis, whereas hemoglobin and 25(OH)D3 were protective factors (P < 0.05).ConclusionUFPWV allows for early and accurate detection of changes in arterial elasticity and enables early intervention to reduce the incidence of cardiovascular events in patients with RA.

scholarly journals POS0563 THE NATURAL COURSE OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE FOCUSING ON LUNG PHYSIOLOGY AND DISEASE ACTIVITY: A PROSPECTIVE COHORT STUDY (PART 2)

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 516.1-516
Author(s):  
S. H. Chang ◽  
J. S. Lee ◽  
J. S. Lee ◽  
C. H. Park ◽  
M. U. Kim ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Disease Activity ◽  
Natural Course ◽  
Annual Change ◽  
Low Disease Activity ◽  
Activity Group ◽  
Lung Physiology ◽  
Group A ◽  
Group B ◽  
Group D

Background:Interstitial lung disease (ILD) is a severe extra-articular manifestation of rheumatoid arthritis (RA). However, the effect of RA disease activity on the course of ILD is not yet known.Objectives:To assess the natural course of lung physiology of RA-ILD and the relation between arthritis activity and pulmonary physiology in patients with RA-ILD.Methods:The Korean Rheumatoid Arthritis ILd (KORAIL) cohort is the prospective observational cohort and aims to investigate the natural course of RAILD. Based on either 1987 or 2020 ACR criteria, patients diagnosed with RA and ILD based on CT scan were recruited from six tertiary medical hospitals in Korea since January 2015. RA disease activity was assessed using disease activity (DAS)28-ESR and CRP, annually. Pulmonary function tests (PFT), including FVC and DLCO were conducted annually. According to the transition of DAS28-ESR status, we classified patients into four groups: Group A. persistent remission or low disease activity, Group B. improvement, Group C. worsening, Group D. persistent moderate to high disease activity.Results:We analyzed 143 patients who completed a 2-year follow-up (visit 2) or had died with available PFT results at least twice. Mean duration since RA diagnosis and since ILD diagnosis was 7.6±8.0 and 2.7±3.1 years, respectively. Twenty-four patients were Group A, 33 Group B, 10 Group C and 30 Group D. The mean of FVC (mL) and % of the predicted value in FVC was significantly lower in Group D than in other groups (Table 1). The annual rate of decline in FVC was -42 (95% CI -93~10) mL·year-1 in Group B while -113 (95% CI -206~-21) mL·year-1 in Group C (Figure 1A). The annual decline rate in Group C was further exaggerated in patients with ≥ 80% of FVC predicted (-141, 95% CI -251~-32 mL·year-1). During two years of follow-up, patients ever experienced a relative decline of ≥10% from the enrollment in FVC predicted was 27.3%(n-9/33) in Group B whereas 30.0% (3/10) in Group C. The annual rate of decline in % of DLco predicted value was also the largest in Group C (-4.6 %·year-1, 95%CI -8.5~-0.7), which further exaggerated in patients with ≥ 80% of FVC predicted (-4.9%·year-1, 95 %CI -8.3~-1.5, Figure 1B). Of note, about half of patients with maintained not only low disease activity (Group A) but also moderate to severe disease activity (Group D) improved in DLco at least 10% or more from the enrollment of DLco predicted value (Group A: 54.2%, n=13/24, Group D: 46.7%, n=14/30).Conclusion:RA disease activity is associated with the change of lung physiology in patients with RA-ILD; worsening disease activity associated with a further decrease of annual change in FVC and maintaining low disease activity associated with a further increase of annual change in % of DLco predicted value.Table 1.The analysis of forced vital capacity (FVC) according to disease activity transition group.Group AGroup BGroup CGroup DFVC (mL), mean±SD2810.0±771.12528.8±735.32801.0±952.72048.3±575.7FVC % of predicted, mean±SD87.5±14.586.5±16.693.0±15.677.2±17.3Rate of FVC decline, mL·year-1 (95% CI)-52 (-112,7)-42 (-93,10)-113 (-206, -21)1 (-52, 54)A 10-point decline from V1 in predicted FVC value, n (%)29 (20.3)6 (25.0)6 (18.2)3 (30.0)Relative decline of 10% from the enrollment in predicted FVC value, n (%)35 (24.5)5 (20.8)9 (27.3)3 (30.0)Figure 1.The annual change of pulmonary physiology according to disease activity transition group.Acknowledgements:This work was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant no.HI14C1277).Disclosure of Interests:None declared

Pulse Wave Velocity: A Valuable Predictor for Cardio-Cerebrovascular Disease and Death in PD Patients

2015 ◽  
Vol 40 (3) ◽  
pp. 203-208 ◽  
Author(s):  
Tian Xu ◽  
Jingyuan Xie ◽  
Xue Zong ◽  
Weiming Wang ◽  
Hong Ren ◽  
...  
Keyword(s):  
Risk Factors ◽  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
Survival Rates ◽  
Left Ventricular ◽  
Average Systolic Blood Pressure ◽  
Group A ◽  
Group B ◽  
Valuable Predictor

Aims: To evaluate the value of pulse wave velocity (PWV) to predict cardio-cerebrovascular (CVD) and death in peritoneal dialysis (PD) patients. Methods: In all, 59 maintenance PD patients from January 2012 to December 2012 were enrolled. Patients were classified as group A (>9 m/s) and group B (≤9 m/s), based on the results of carotid-femoral PWV (CF-PWV). Results: CF-PWV was positively correlated with age (r = 0.71, p < 0.01), left atrial diameter (r = 0.58, p < 0.01), left ventricular mass index (r = 0.59, p < 0.01) and 24H average systolic blood pressure (SBP) (r = 0.57, p < 0.01). Age (relative risk (RR) 1.086, 95% confidence interval (CI) 1.024-1.153, p < 0.01) and 24H average SBP (RR 1.047, 95% CI 1.013-1.082, p < 0.01) were risk factors of higher CF-PWV. The cumulative and new CVD free survival rates of group A significantly decreased. Elder (RR 1.114, 95% CI 1.013-1.224, p = 0.026) and higher PWV (RR 1.482, 95% CI 1.01-2.176, p = 0.044) were risk factors of CVD in PD patients. Conclusion: PWV is a valuable predictor of CVD and death in PD patients.

scholarly journals Cardiopulmonary Function Assessment in Children With Pulmonary Valve Stenosis

2022 ◽  
Vol 9 ◽  
Author(s):  
Li Yun Teng ◽  
Sen Wei Tsai ◽  
Chun Yuan Hsiao ◽  
Wei Hung Sung ◽  
Ko Long Lin
Keyword(s):  
Pulmonary Artery ◽  
Pulse Wave Velocity ◽  
Pulmonary Function ◽  
Exercise Performance ◽  
Pulse Wave ◽  
Pulmonary Valve ◽  
Follow Up Care ◽  
Group A ◽  
Group B

ObjectivePulmonary valve (PV) stenosis affects cardiac pulmonary function and exercise performance. A cardiopulmonary exercise test (CPET) combined with a transthoracic echocardiogram (TTE) can measure exercise performance, disease progression, and treatment effects. We assessed the exercise capacity in children with PV stenosis by conducting CPET and TTE.MethodsFrom 2005 to 2021, 84 patients with PV stenosis aged 6–18 years were enrolled; 43 were treated with balloon pulmonary valvuloplasty (BPV) (Group A), and 41 received follow-up care (Group B), and their CPET and pulmonary function test results were compared with 84 healthy, matched individuals (Control). We also conducted TTE to compare the peak pulmonary artery pulse wave velocity and pulmonary valve (PV) area before and after catheterization and follow-up care.ResultsThere were no significant differences among the CPET parameters of the patient groups and controls in anaerobic metabolic equivalent (MET) (group A: 6.44 ± 0.58; group B: 6.28 ± 0.47, control: 6.92 ± 0.39, p = 0.110), peak MET (group A: 9.32 ± 0.74; group B: 9.13 ± 0.63; control: 9.80 ± 0.52, p = 0.263), and heart rate recovery (group A: 28.04 ± 4.70; group B: 26.44 ± 3.43, control:26.10 ± 2.42, p = 0.718). No significant differences were found in the pulmonary functions between the three groups. The pulmonary artery pulse wave velocity significantly decreased after catheterization (3.97 ± 1.50 vs. 1.95 ± 0.94, p &lt; 0.0001), but not after follow-up care (1.67 ± 0.77 vs. 1.75 ± 0.66, p = 0.129). The pulmonary vale area significantly improved in group A (0.89 ± 0.71 vs. 1.16 ± 0.58, p &lt; 0.0001), whereas only insignificant progression of PV stenosis was observed in group B (1.60 ± 0.64 vs. 1.57 ± 0.65, p = 0.110).ConclusionsPatients treated with BPV had a similar exercise capacity with that of patients under follow-up care and the healthy controls. Larger or multi-center studies should be conducted to confirm the physical fitness of pediatric patients with PV stenosis after management.

scholarly journals Assessment of the Cardioankle Vascular Index in Pregnant Women Complicated with Hypertensive Disorders

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Atsushi Yoshida ◽  
Takashi Sugiyama ◽  
Norimasa Sagawa
Keyword(s):  
Blood Pressure ◽  
Pregnant Women ◽  
Pulse Wave ◽  
Chronic Hypertension ◽  
Significant Difference ◽  
Group A ◽  
The Subject ◽  
The Difference ◽  
Group B ◽  
Group D

It was previously reported that the brachial-ankle pulse wave velocity (baPWV) is elevated in preeclamptic women. However, baPWV is strongly affected by blood pressure. Recently, a new index of vascular stiffness, the cardioankle vascular index (CAVI), was developed. CAVI is thought to be an index independent of blood pressure. We assessed CAVI in normotensive and hypertensive pregnant women. We studied a total of 109 Japanese women consisting of 23 nonpregnant healthy women (group A), 45 normotensive pregnant women (group B), 28 pregnant women complicated with established preeclampsia (group C), and 13 pregnant women with chronic hypertension (group D). The subject remained supine while the blood pressure, baPWV, and CAVI were recorded. No significant difference in baPWV was present between groups C and D, but the difference in CAVI was significantly high in group D. We believe that we can distinguish the vessel structural change between chronic hypertension and preeclampsia through simultaneous baPWV and CAVI measurements.

scholarly journals The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus

Medicina ◽  
2010 ◽  
Vol 46 (8) ◽  
pp. 522 ◽  
Author(s):  
Alma Čypienė ◽  
Jolanta Dadonienė ◽  
Rita Rugienė ◽  
Ligita Ryliškytė ◽  
Milda Kovaitė ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Systemic Lupus Erythematosus ◽  
Blood Pressure ◽  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Lupus Erythematosus ◽  
Pulse Wave ◽  
Augmentation Index ◽  
Mean Blood Pressure ◽  
Systemic Lupus

Objective. To investigate the carotid-radial pulse wave velocity, augmentation index, and flow-mediated dilation of the brachial artery and factors possibly influencing them in women with rheumatoid arthritis and systemic lupus erythematosus. Material and methods. A total of 63 women with rheumatoid arthritis, 31 with systemic lupus erythematosus, and 72 controls, aged 18–55 years, were examined. Parameters of arterial stiffness, augmentation index and carotid-radial pulse wave velocity, were obtained by applanation tonometry (Sphygmocor (v.7.01) AtCor Medical). Flow-mediated dilatation of the brachial artery, reflecting endothelial function was determined by ultrasound system (Logiq 7, General Electric). Results. The groups of women with rheumatoid arthritis and systemic lupus erythematosus lupus differed from controls regarding augmentation index (P<0.001; P=0.008) and did not differ between each other. Women with systemic lupus erythematosus differed from controls regarding pulse wave velocity (P=0.018), while women with rheumatoid arthritis – did not. Flow-mediated dilatation in both the groups of diseases was not different from controls. In rheumatoid arthritis patients, mean blood pressure was the main explanatory factor for augmentation index and pulse wave velocity; vessel diameter and high-density lipoprotein cholesterol – for flow-mediated dilatation. In women with systemic lupus erythematosus, pulse wave velocity was not related to any of the pending parameters; augmentation index was dependent on organ damage index, age, and mean blood pressure, and flow-mediated dilatation on vessel diameter, body mass index, and disease duration. Conclusions. The mean blood pressure was the major and the only one risk factor of arterial stiffening in rheumatoid arthritis, while the disease damage index played the most important role in the systemic lupus erythematosus group. The mean blood pressure in the systemic lupus erythematosus group was not as important as in the rheumatoid arthritis group, though may have a partial influence.

scholarly journals Cardiovascular Autonomic Function in Individuals with Rheumatoid Arthritis

2018 ◽  
Vol 3 (12) ◽  
Author(s):  
Dr. Pranjali Deshpande ◽  
Dr. Deepak S. Howale
Keyword(s):  
Rheumatoid Arthritis ◽  
Blood Pressure ◽  
Nervous System ◽  
Autonomic Function ◽  
Control Group ◽  
Healthy Individuals ◽  
American College Of Rheumatology ◽  
Cardiovascular Autonomic Function ◽  
Group A ◽  
Group B

Rheumatoid arthritis is common inflammatory arthritis arising throughout the world. A chronic systemic inflammatory autoimmune disorder is known as Rheumatoid arthritis (RA). Principally it affects the joints and usually accompanied by one or more of extra-articular manifestations as rheumatoid nodules, neuropathy and norm chromic normocytic anemia. Rheumatoid arthritis can start at any age, but has maximum between 35 to 55 years of age. The prevalence of RA is about 1% worldwide whereas India is 0.9% with women suffering 3-5 times more than men. Sympathetic and parasympathetic involvement has described in primary and secondary vasculitis processes, as in systemic vasculitis processes like: SLE, RA. Peripheral nervous system is the main target in RA patients where as involvement of central nervous system (CNS) is rare. The aim of this study was to evaluate cardiac autonomic function in RA and compare with healthy individuals by using HRT analysis. Materials and Methods: A cross-sectional study was performed which was carried out in the Dept. of Physiology at Zydus Medical College and Hospital. It was carried out on both males and females of mean age group 45±10 years to study autonomic functions in RA. Total 50 individuals were include in which 25 were included as healthy individuals with not on any medication, served as controls and 25 were diagnosed with RA, on the basis of criteria developed by American College of Rheumatology along with sex matched controls. Details of history and examination were recorded on Performa. Patients were examined for signs and symptoms of possible Autonomic Nervous System (ANS) dysfunctions. Result: 50 individuals were include in this study which were grouped into Study group (Group – A) and Control group (Group – B). Group – A consisted of 25 individuals who were diagnosed with rheumatoid arthritis on basis of criteria developed by American College of Rheumatology. Group – B consisted of 25 healthy individuals not on any medication as to explain normal changes. The 30:15 ratio and valsalva maneuver demonstrated a less decrease but was non-significant statistically in the patients with Rheumatoid Arthritis as compared to control (p>0.05). On standing the blood pressure response the change in diastolic blood pressure was significantly (P<0.01) lower in groups A as compared to control. Conclusion: Cardiovascular autonomic function tests in routine clinical examination helpful in early detection of autonomic dysfunction in this disease. Further comprehensive information are useful about autonomic function may be extracted from global evaluation of all tests performed. Therefore testing of autonomic function may be the part of routine clinical evaluation in RA to reduce the cardiovascular autonomic morbidity.

Bioinformatics Study on Serum Triglyceride Levels for Analysis of a Potential Risk Factor Affecting Blood Pressure Variability

2019 ◽  
Vol 14 (5) ◽  
pp. 376-385 ◽  
Author(s):  
Lin Xu ◽  
Jiangming Huang ◽  
Zhe Zhang ◽  
Jian Qiu ◽  
Yan Guo ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Systolic Blood Pressure ◽  
Blood Pressure Variability ◽  
Partial Correlation ◽  
Pearson Correlation ◽  
Target Organ Damage ◽  
Serum Triglyceride ◽  
Hypertensive Patients ◽  
Group A ◽  
Group B

Objective: The purpose of this study was to establish whether Triglycerides (TGs) are related to Blood Pressure (BP) variability and whether controlling TG levels leads to better BP variability management and prevents Cardiovascular Disease (CVD). Methods: In this study, we enrolled 106 hypertensive patients and 80 non-hypertensive patients. Pearson correlation and partial correlation analyses were used to define the relationships between TG levels and BP variability in all subjects. Patients with hypertension were divided into two subgroups according to TG level: Group A (TG<1.7 mmol/L) and Group B (TG>=1.7 mmol/L). The heterogeneity between the two subgroups was compared using t tests and covariance analysis. Results: TG levels and BP variability were significantly different between the hypertensive and non-hypertensive patients. Two-tailed Pearson correlation tests showed that TG levels are positively associated with many BP variability measures in all subjects. After reducing other confounding factors, the partial correlation analysis revealed that TG levels are still related to the Standard Deviation (SD), Coefficient of Variation (CV) of nighttime systolic blood pressure and CV of nighttime diastolic blood pressure, respectively (each p<0.05). In the subgroups, group A had a lower SD of nighttime Systolic Blood Pressure (SBP_night_SD; 11.39±3.80 and 13.39±4.16, p=0.011), CV of nighttime systolic blood pressure (SBP_night_CV; 0.09±0.03 and 0.11±0.03, p=0.014) and average real variability of nighttime systolic blood pressure (SBP_night_ARV; 10.99±3.98 and 12.6±3.95, p=0.024) compared with group B, even after adjusting for age and other lipid indicators. Conclusion: TG levels are significantly associated with BP variability and hypertriglyceridemia, which affects blood pressure variability before causing target organ damage.

Sign in / Sign up

Export Citation Format

Share Document